2a, 3a, 4p and 5a,g,k and o and Extended Data Figs
422 Topical administration of the TLR7 agonist imiquimod was shown to increase antigen-bearing cDC2 populations, resulting in partial restoration of vaccination efficacy through targeted phenotypic restoration
Metabolic Pathway Analysis Researchers use IGF-1 LR3 to study interactions between growth-factor signaling and metabolic processes, including glucose uptake, lipid utilization, and energy production
doi: 10.12968/bjtr.1998.5.4.14088 39 SpeightN
Regulatory status at a glance What this means in practice If you use a topical GHK-Cu serum, it is a legally sold cosmetic, not an approved drug
Supplies Needed Plan based on daily use protocol: Peptide Vials (Ipamorelin 10mg): 8 weeks approx